Lower urinary connective tissue growth factor levels and incident CKD stage 3 in the general population

American Journal of Kidney Diseases

Volumn 57, Issue 6, 2011, Pages 841-849

  O'Seaghdha, Conall M ^a,b   Hwang, Shih Jen ^a   Bhavsar, Nrupen A ^c,d   Kttgen, Anna ^c,e   Coresh, Josef ^c,d,f   Astor, Brad C ^c,d,f   Fox, Caroline S ^a,g,h  

^a NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

^c JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^d JOHNS HOPKINS UNIVERSITY   (United States)

^e UNIVERSITY OF FREIBURG   (Germany)

^f JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^g BRIGHAM AND WOMEN S HOSPITAL   (United States)

^h FRAMINGHAM HEART STUDY   (United States)

Author keywords

Chronic kidney disease; connective tissue growth factor; epidemiology

Indexed keywords

CONNECTIVE TISSUE GROWTH FACTOR; HIGH DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; AGED; ARTICLE; BODY MASS; CASE CONTROL STUDY; CHRONIC KIDNEY DISEASE; CONTROLLED STUDY; CREATININE URINE LEVEL; DIABETES MELLITUS; DISEASE COURSE; FEMALE; FOLLOW UP; GLOMERULUS FILTRATION RATE; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; META ANALYSIS; MICROALBUMINURIA; RISK; SYSTOLIC BLOOD PRESSURE; URINALYSIS;

BIOLOGICAL MARKERS; CONNECTIVE TISSUE GROWTH FACTOR; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; GLOMERULAR FILTRATION RATE; HUMANS; INCIDENCE; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; NEPHELOMETRY AND TURBIDIMETRY; POPULATION SURVEILLANCE; PROGNOSIS; PROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; UNITED STATES;

EID: 79956355440     PISSN: 02726386     EISSN: 15236838     Source Type: Journal    
DOI: 10.1053/j.ajkd.2010.11.022     Document Type: Article

References (53)

1. J. Coresh, E. Selvin, and L.A. Stevens Prevalence of chronic kidney disease in the United States JAMA 298 17 2007 2038 2047 (Pubitemid 350074801)
2. Q.L. Zhang, and D. Rothenbacher Prevalence of chronic kidney disease in population-based studies: systematic review BMC Public Health 8 2008 117
3. S.J. Chadban, E.M. Briganti, and P.G. Kerr Prevalence of kidney damage in Australian adults: the AusDiab kidney study J Am Soc Nephrol 14 7 suppl 2 2003 S131 S138
4. J. Chen, R.P. Wildman, and D. Gu Prevalence of decreased kidney function in Chinese adults aged 35 to 74 years Kidney Int 68 6 2005 2837 2845 (Pubitemid 43251031)
5. V. Perkovic, A. Cass, and A.A. Patel High prevalence of chronic kidney disease in Thailand Kidney Int 73 4 2008 473 479 (Pubitemid 351192918)
6. H. Tanaka, Y. Shiohira, Y. Uezu, A. Higa, and K. Iseki Metabolic syndrome and chronic kidney disease in Okinawa, Japan Kidney Int 69 2 2006 369 374 (Pubitemid 43323089)
7. W.M. McClellan, and W.D. Flanders Risk factors for progressive chronic kidney disease J Am Soc Nephrol 14 7 suppl 2 2003 S65 S70
8. P. Muntner, S. Vupputuri, J. Coresh, J. Uribarri, and C.S. Fox Metabolic abnormalities are present in adults with elevated serum cystatin C Kidney Int 76 1 2009 81 88
9. C.Y. Hsu, C.E. McCulloch, and G.C. Curhan Epidemiology of anemia associated with chronic renal insufficiency among adults in the United States: results from the Third National Health and Nutrition Examination Survey J Am Soc Nephrol 13 2 2002 504 510 (Pubitemid 34106294)
10. K.E. Ensrud, L.Y. Lui, and B.C. Taylor Renal function and risk of hip and vertebral fractures in older women Arch Intern Med 167 2 2007 133 139 (Pubitemid 46148060)
11. L.F. Fried, M.G. Shlipak, and C. Crump Renal insufficiency as a predictor of cardiovascular outcomes and mortality in elderly individuals J Am Coll Cardiol 41 8 2003 1364 1372 (Pubitemid 36438998)
12. D.E. Weiner, H. Tighiouart, and M.G. Amin Chronic kidney disease as a risk factor for cardiovascular disease and all-cause mortality: a pooled analysis of community-based studies J Am Soc Nephrol 15 5 2004 1307 1315 (Pubitemid 38526012)
13. D. de Zeeuw, D. Ramjit, and Z. Zhang Renal risk and renoprotection among ethnic groups with type 2 diabetic nephropathy: a post hoc analysis of RENAAL Kidney Int 69 9 2006 1675 1682
14. P. Ruggenenti, A. Perna, and G. Gherardi Renoprotective properties of ACE-inhibition in non-diabetic nephropathies with non-nephrotic proteinuria Lancet 354 9176 1999 359 364 (Pubitemid 29355751)
15. H. Makino, Y. Nakamura, and J. Wada Remission and regression of diabetic nephropathy Hypertens Res 26 7 2003 515 519 (Pubitemid 36974992)
16. B. Rodriguez-Iturbe, R.J. Johnson, and J. Herrera-Acosta Tubulointerstitial damage and progression of renal failure Kidney Int Suppl 99 2005 S82 S86
17. N. Wardle Glomerulosclerosis: the final pathway is clarified, but can we deal with the triggers? Nephron 73 1 1996 1 7 (Pubitemid 26125515)
18. W.A. Border, and N.A. Noble TGF-beta in kidney fibrosis: a target for gene therapy Kidney Int 51 5 1997 1388 1396 (Pubitemid 27239888)
19. G.S. Kuncio, E.G. Neilson, and T. Haverty Mechanisms of tubulointerstitial fibrosis Kidney Int 39 3 1991 550 556
20. H.W. Schnaper, S. Jandeska, and C.E. Runyan TGF-beta signal transduction in chronic kidney disease Front Biosci 14 2009 2448 2465
21. E.P. Bottinger, and M. Bitzer TGF-beta signaling in renal disease J Am Soc Nephrol 13 10 2002 2600 2610
22. G.R. Grotendorst Connective tissue growth factor: a mediator of TGF-beta action on fibroblasts Cytokine Growth Factor Rev 8 3 1997 171 179 (Pubitemid 28077925)
23. Y. Ito, R. Goldschmeding, and R. Bende Kinetics of connective tissue growth factor expression during experimental proliferative glomerulonephritis J Am Soc Nephrol 12 3 2001 472 484 (Pubitemid 32180016)
24. H. Yokoi, M. Mukoyama, and A. Sugawara Role of connective tissue growth factor in fibronectin expression and tubulointerstitial fibrosis Am J Physiol Renal Physiol 282 5 2002 F933 F942
25. Y. Ito, J. Aten, and R.J. Bende Expression of connective tissue growth factor in human renal fibrosis Kidney Int 53 4 1998 853 861 (Pubitemid 28155657)
26. I.E. Blom, A.J. van Dijk, and L. Wieten In vitro evidence for differential involvement of CTGF, TGFbeta, and PDGF-BB in mesangial response to injury Nephrol Dial Transplant 16 6 2001 1139 1148 (Pubitemid 32547367)
27. W.B. Kannel, M. Feinleib, P.M. McNamara, R.J. Garrison, and W.P. Castelli An investigation of coronary heart disease in families The Framingham Offspring Study Am J Epidemiol 110 3 1979 281 290 (Pubitemid 10204328)
28. The Atherosclerosis Risk in Communities (ARIC) Study: design and objectives The ARIC investigators Am J Epidemiol 129 4 1989 687 702
29. B.A. Wasserman, B.C. Astor, A.R. Sharrett, C. Swingen, and D. Catellier MRI measurements of carotid plaque in the Atherosclerosis Risk in Communities (ARIC) Study: methods, reliability and descriptive statistics J Magn Reson Imaging 31 2 2010 406 415
30. A.S. Levey, J.P. Bosch, J.B. Lewis, T. Greene, N. Rogers, and D. Roth A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation Modification of Diet in Renal Disease Study Group Ann Intern Med 130 6 1999 461 470 (Pubitemid 29135798)
31. National Kidney Foundation K/DOQI Clinical Practice Guidelines for Chronic Kidney Disease: evaluation, classification, and stratification Am J Kidney Dis 39 2 suppl 1 2002 S1 S266
32. C.S. Fox, M.G. Larson, E.P. Leip, B. Culleton, P.W. Wilson, and D. Levy Predictors of new-onset kidney disease in a community-based population JAMA 291 7 2004 844 850 (Pubitemid 38543772)
33. A. Kottgen, S.J. Hwang, and M.G. Larson Uromodulin levels associate with a common UMOD variant and risk for incident CKD J Am Soc Nephrol 21 2 2010 337 344
34. C.C. Hsu, F.L. Brancati, and B.C. Astor Blood pressure, atherosclerosis, and albuminuria in 10,113 participants in the Atherosclerosis Risk in Communities Study J Hypertens 27 2 2009 397 409
35. P. Bornstein Matricellular proteins: an overview J Cell Commun Signal 3 3-4 2009 163 165
36. A. Leask, and D.J. Abraham All in the CCN family: essential matricellular signaling modulators emerge from the bunker J Cell Sci 119 pt 23 2006 4803 4810 (Pubitemid 46017793)
37. X. Shi-Wen, A. Leask, and D. Abraham Regulation and function of connective tissue growth factor/CCN2 in tissue repair, scarring and fibrosis Cytokine Growth Factor Rev 19 2 2008 133 144 (Pubitemid 351382279)
38. I. Cicha, and M. Goppelt-Struebe Connective tissue growth factor: context-dependent functions and mechanisms of regulation Biofactors 35 2 2009 200 208
39. O.V. Sakharova, M.W. Taal, and B.M. Brenner Pathogenesis of diabetic nephropathy: focus on transforming growth factor-beta and connective tissue growth factor Curr Opin Nephrol Hypertens 10 6 2001 727 738 (Pubitemid 33043665)
40. M. Murphy, C. Godson, and S. Cannon Suppression subtractive hybridization identifies high glucose levels as a stimulus for expression of connective tissue growth factor and other genes in human mesangial cells J Biol Chem 274 9 1999 5830 5834 (Pubitemid 29109239)
41. S. Wang, M. Denichilo, C. Brubaker, and R. Hirschberg Connective tissue growth factor in tubulointerstitial injury of diabetic nephropathy Kidney Int 60 1 2001 96 105 (Pubitemid 32587544)
42. W. Qi, X. Chen, P. Poronnik, and C.A. Pollock Transforming growth factor-beta/connective tissue growth factor axis in the kidney Int J Biochem Cell Biol 40 1 2008 9 13 (Pubitemid 350064576)
43. G. Zhou, C. Li, and L. Cai Advanced glycation end-products induce connective tissue growth factor-mediated renal fibrosis predominantly through transforming growth factor beta-independent pathway Am J Pathol 165 6 2004 2033 2043 (Pubitemid 39578381)
44. H. Yokoi, M. Mukoyama, and T. Nagae Reduction in connective tissue growth factor by antisense treatment ameliorates renal tubulointerstitial fibrosis J Am Soc Nephrol 15 6 2004 1430 1440 (Pubitemid 38679668)
45. R.E. Gilbert, A. Akdeniz, and S. Weitz Urinary connective tissue growth factor excretion in patients with type 1 diabetes and nephropathy Diabetes Care 26 9 2003 2632 2636 (Pubitemid 37052112)
46. T.Q. Nguyen, L. Tarnow, and S. Andersen Urinary connective tissue growth factor excretion correlates with clinical markers of renal disease in a large population of type 1 diabetic patients with diabetic nephropathy Diabetes Care 29 1 2006 83 88 (Pubitemid 44033436)
47. F.W. Tam, B.L. Riser, K. Meeran, J. Rambow, C.D. Pusey, and A.H. Frankel Urinary monocyte chemoattractant protein-1 (MCP-1) and connective tissue growth factor (CCN2) as prognostic markers for progression of diabetic nephropathy Cytokine 47 1 2009 37 42
48. A. Igarashi, H. Okochi, D.M. Bradham, and G.R. Grotendorst Regulation of connective tissue growth factor gene expression in human skin fibroblasts and during wound repair Mol Biol Cell 4 6 1993 637 645 (Pubitemid 23183611)
49. I.E. Blom, R. Goldschmeding, and A. Leask Gene regulation of connective tissue growth factor: new targets for antifibrotic therapy? Matrix Biol 21 6 2002 473 482 (Pubitemid 35248272)
50. L.M. Wakefield, and C. Stuelten Keeping order in the neighborhood: new roles for TGFbeta in maintaining epithelial homeostasis Cancer Cell 12 4 2007 293 295 (Pubitemid 47539313)
51. L. Gewin, N. Bulus, and G. Mernaugh TGF-beta receptor deletion in the renal collecting system exacerbates fibrosis J Am Soc Nephrol 21 8 2010 1334 1343
52. J.B. Kopp TGF-beta signaling and the renal tubular epithelial cell: too much, too little, and just right J Am Soc Nephrol 21 8 2010 1241 1243
53. W. Qi, X. Chen, and J. Holian Transforming growth factor-beta1 differentially mediates fibronectin and inflammatory cytokine expression in kidney tubular cells Am J Physiol Renal Physiol 291 5 2006 F1070 F1077